Companion Diagnostic (CD) Market is raised during the forecast period 2013 - 2020
To view the complete report, visit us at http://www.alliedmarketresearch.com/companion-diagnostic-technologies-market
Companion diagnostic (CD) is an in-vitro diagnostic technique that provides information about therapeutic responses of patient to a specific treatment. Companion diagnostics helps in identification of patients who would benefit from the treatment using certain therapeutic product which would result in improved treatment outcomes and decrease expenditure on healthcare.
In addition, CD also helps in identifying the patient pool that is most likely to respond to the therapeutic treatment; therefore, rules out therapies that would be ineffective. Additionally, it also saves patients from adverse side effects due to ineffective therapies, leading to reduced cost. Rising incidence of cancer, increasing adverse reactions due to drugs and personalized treatment approach is pushing R&D efforts to focus on development of targeted therapies. Technological advancement and discovery of new biomarkers is also driving growth of this market.
Request For Customization:- https://www.alliedmarketresearch.com/request-for-customization/135
However, coordinating the development of companion diagnostics and therapeutic products is a challenge for this market. Nevertheless, the increasing incidences of cancer, cardiovascular conditions, central nervous system conditions has resulted in significant investments in research and development of targeted therapies, which would need corresponding companion diagnostics and would be an opportunity for growth of this market.
Companion diagnostics market by indication is segmented into oncology, cardiovascular, CNS, autoimmune & inflammation, virology and others. Presently, majority of the companion diagnostics have been developed for cancer and thus, it is the major revenue generating segment in the overall CD indication market. Companion diagnostics have been developed for breast cancer, lung cancer, colorectal cancer, gastric cancer and melanomas.
Inquiry Before Buying:- https://www.alliedmarketresearch.com/purchase-enquiry/135
Companion diagnostics for breast cancer is the highest revenue generator mainly because there has been an increase in the incidences of breast cancer and many companion diagnostics have been developed for detection of the HER/neu biomarker for breast cancer. As of now, companion diagnostics for cardiovascular conditions, central nervous system conditions , inflammation and autoimmune diseases and viral diseases are very few, with a majority still in development stage; however, as more and more biomarkers are being discovered, there would be an increase in development of new companion diagnostics.
Similar market studies by Allied Market Research -
Global Synthetic Biology Market - http://www.alliedmarketresearch.com/synthetic-biology-market
Global Bioinformatics Market - http://www.alliedmarketresearch.com/bioinformatics-market
Global Tissue Engineering and Regeneration Market - http://www.alliedmarketresearch.com/tissue-engineering-and-regeneration-market
Global Forensic Technologies Market - http://www.alliedmarketresearch.com/forensic-technologies-market
Global Cardiac Biomarkers Market - http://www.alliedmarketresearch.com/cardiac-biomarkers-market
View all Diagnostic and Biotech market studies at - http://www.alliedmarketresearch.com/diagnostic-and-biotech-market-report
5320 SW Macadam Avenue,
Suite 100, Portland, OR 97239
Toll Free: +1-(855)-711-1555 (U.S. & Canada)
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in capturing most accurate market data and confirms utmost accuracy of our market forecasts. Each and every data presented in the reports published by us is also extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Companion Diagnostic (CD) Market is raised during the forecast period 2013 - 2020 here
News-ID: 2267271 • Views: 160
More Releases from Allied Market Research
Mosquito Trap Market Size Comprehensive Analysis, Growth Forecast from 2020-2027 …
The global Mosquito trap market is experiencing significant growth, and will grow considerably in the next few years. Increasing concern over the health and hygiene of people anticipating innovative mosquito traps in the market. Mosquito electric killer attracts and kills mosquitoes without the use of smoke, harmful chemicals, or dangerous high-voltage equipment. Unlike other similar units, the lamp uses 6 low-voltage LED's to attract flying mosquitoes. For maximum attraction, the
Motorcycle Helmet Market Opportunities, Drivers Size, Share, Value, And Competit …
Motorcycle helmets are used by bikers for protection of heads while riding a motorcycle. The primary objective of a motorcycle helmet is motorcycle safety to secure the rider’s head during impact, hence preventing head injury and saving the life. Helmets come in various designs and comfort to cater to consumer requirements. Helmets give extra comforts, such as ventilation, face shields, ear protection. The motorcycle classified into two types for application
Impact of COVID-19 on Zero-waste Shampoo Market 2021 | Trends, Growth Demand, Op …
Allied Market Research published a new report, titled, ” Zero-Waste Shampoo Market ” The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage. The zero-waste shampoo
Microscope Market Share and Rising Demand (2021-2028): Latest Updates and Key Ma …
Allied Market Research published a new report, titled, "Microscope Market By Type (Scanning Electron Microscope, Transmission Electron Microscope, Focused Ion Beam, and Others) and End Use (Semiconductor & Microelectronics, Healthcare, General Manufacturing, Food Processing, Construction, and Other): Global Opportunity Analysis and Industry Forecast, 2020–2027". The report provides a detailed study of the global microscope market covering a number of important aspects such as current market scenario, estimates, top investment pockets, recent
More Releases for Companion
Companion Diagnostics Market – Growth , Opportunities and Applications
Companion diagnostics are tests to understand which patient can be benefited from a certain drug or what dosage should be prescribed based upon patient’s clinical diagnosis, which provides evidence required for the successful and harmless use of an equivalent drug or biological product to treat the medical condition. These are medical instruments that support doctors to elect which treatment and dosage should be given to patients personalized to their necessity. Companion
A Smart Companion to your TV
Following HELLO’s very successful Kickstarter campaign (1339% funded), Solaborate is launching the new and improved HELLO 2 on Kickstarter, along with HELLO Touch TV, HELLO Creator Edition and 2 Gadget Extensions. A Smart Companion to your TV HELLO 2, like its predecessor, turns any TV into a video communication and collaboration device. HELLO 2 does everything users love about the original even better with Alexa support, home automation (Zigbee), and Android games,
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test
Global Farm & Companion Animal Health Market
Veterinary healthcare products include pharmaceuticals, nutrition (feed additives) and devices for both companion and livestock animals. Companion animals include pets such as dogs, cats and horses; although in recent years the market has expanded reasonably for avian pets, reptiles and exotic fish. The healthcare products have transformed the health and quality of life for millions of pets across the world. The greatest challenge of maintaining pets is seeking the keenness
Global Companion Diagnostics Market to Grow Globally
Companion diagnostic (CDx) is a diagnostic tool used to determine the suitability of a drug therapy to the patient. It has become a critical part of targeted cancer therapy that allows for development of personalized therapy can be developed and administered to the patient. Whole blood samples, tissues samples, or buccal samples are collected and tested for diagnosis and identification of targeted disease biomarker. CDx is usually utilized in identifying
Global Companion Diagnostics – Growth Companion for Personalized Medicine
Companion Diagnostics: Growth Companion for Personalized Medicine Personalized medicine is the new segment in discussion among healthcare experts around the globe. Also, encouragement from the regulatory bodies such as the FDA and EMEA in erms of providing a defined structure for companion diagnostic development is driving research activities in personalized medicine. Diagnosis at molecular level for each individual is of prime importance to identify the target biomarker before deciding the therapy.